• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, July 31, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

New heart attack testing protocol expedites treatment in ER

Bioengineer by Bioengineer
April 22, 2020
in Health
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: UTSW

DALLAS – April 22, 2020 – A new protocol using highly sensitive blood tests to determine whether someone is having a heart attack can reduce wait times and overcrowding in emergency departments, according to a new study from UT Southwestern Medical Center.

The findings, published online today in JAMA Open, are particularly meaningful during the current coronavirus pandemic when many people with chest pain may be fearful of going to the hospital.

“Patients are more reluctant to come to the ER with heart-related symptoms during the COVID-19 outbreak. We do not want those with medical emergencies to avoid the hospital due to concern for risk from the virus,” says cardiologist Rebecca Vigen, M.D., assistant professor of internal medicine at UT Southwestern.

The research team led by Vigen found that a new protocol for using high sensitivity cardiac troponin testing can improve efficiency in the ER by more quickly determining which patients are not having a heart attack. Troponins are proteins released when the heart muscle has been damaged. The protocol incorporates the HEART score – history, electrocardiogram, age, risk factors, and troponin – an emergency department risk assessment tool that guides decisions on discharge and stress testing. 

According to the Centers for Disease Control and Prevention, chest pain is the most common reason for trips to the ER, resulting in 7 million annual visits. 

“Our innovative strategy allowed us to ‘rule out’ heart attacks within one hour in more than half of the patients who were tested. This process is safe and improves the efficiency of evaluating patients with possible heart attacks,” says James de Lemos, M.D., professor of internal medicine at UT Southwestern and co-author of the study.

“Emergency room overcrowding has become an urgent health priority that is even more pressing in the current COVID-19 pandemic. Given the large size of the study and its performance during routine operations in our county hospital, we think the findings would apply to many busy U.S. emergency rooms,” de Lemos adds. 

The new protocol was first implemented in December 2017 at Parkland Memorial Hospital, a major safety net hospital in Dallas, and then in October 2018 at UT  Southwestern’s William P. Clements Jr. University Hospital. The study included 31,543 emergency room patients at Parkland from Jan. 1, 2017, to Oct. 16, 2018. Their mean age was 54, the population was racially and ethnically diverse, and 48 percent were women. 

###

Other UTSW researchers who contributed to the study were Dergham Alzubaidy, Sandeep R. Das, Deborah B. Diercks, Ibrahim A. Hashim, Jose A. Joglar, Jeffery C. Metzger, Kyle Molberg, Ambarish Pandey, Jose Soto, and Lin Zhong. Contributing from Parkland Health and Hospital System: Bryan Bertulfo, Fernabelle Fernandez, Patricia Kutscher, Lorie Thibodeaux, and Amy Yu.

de Lemos, who holds the Sweetheart Ball-Kern Wildenthal, M.D., Ph.D. Distinguished Chair in Cardiology, receives grant support from Roche Diagnostics and Abbott Diagnostics and consulting income from Roche Diagnostics, Abbott Diagnostics, Ortho Clinical Diagnostics, and Endpoint Committees for Radiometer, Quidel Cardiovascular Inc., and Siemens Healthcare Diagnostics.

About UT Southwestern Medical Center

UT Southwestern, one of the premier academic medical centers in the nation, integrates pioneering biomedical research with exceptional clinical care and education. The institution’s faculty has received six Nobel Prizes, and includes 22 members of the National Academy of Sciences, 17 members of the National Academy of Medicine, and 14 Howard Hughes Medical Institute Investigators. The full-time faculty of more than 2,500 is responsible for groundbreaking medical advances and is committed to translating science-driven research quickly to new clinical treatments. UT Southwestern physicians provide care in about 80 specialties to more than 105,000 hospitalized patients, nearly 370,000 emergency room cases, and oversee approximately 3 million outpatient visits a year.

Media Contact
Newsroom
[email protected]

Original Source

https://www.utsouthwestern.edu/newsroom/articles/year-2020/New-heart-attack-testing-protocol-expedites-treatment-in-er.html

Related Journal Article

http://dx.doi.org/10.1001/jamanetworkopen.2020.3359

Tags: Medicine/Health
Share13Tweet8Share2ShareShareShare2

Related Posts

Representations of the intrinsic value of information in mouse orbitofrontal cortex

July 30, 2026

Ferroptotic propagation: from single-cell execution to tissue-scale death programs

July 30, 2026

Residential proximity to major roadways and prevalent diabetes in older adults: a cross-sectional study based on CLHLS

July 30, 2026

Regulation of RNA transcript elongation in metazoans and its relevance to disease

July 30, 2026
Please login to join discussion

POPULAR NEWS

  • Cemiplimab and fianlimab with neoadjuvant chemotherapy in early-stage high-risk -negative breast cancer

    29 shares
    Share 12 Tweet 7
  • Combined phage therapy and faecal microbiota transplantation to treat recurrent urinary tract infection: a case series

    29 shares
    Share 12 Tweet 7
  • Representations of the intrinsic value of information in mouse orbitofrontal cortex

    29 shares
    Share 12 Tweet 7
  • Pilot study to validate endothelium collection from pulmonary artery balloon catheter in children

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Cemiplimab and fianlimab with neoadjuvant chemotherapy in early-stage high-risk -negative breast cancer

Combined phage therapy and faecal microbiota transplantation to treat recurrent urinary tract infection: a case series

Representations of the intrinsic value of information in mouse orbitofrontal cortex

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.